India to Uzbekistan: Daunorubicin Export Trade Route

The India to Uzbekistan Daunorubicin corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $84.0K USD. The route is dominated by ZANDRA LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 63% of all export value, reflecting the consolidated nature of India's daunorubicin manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $8.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 14.8%, placing it at rank #16 among India's top daunorubicin export destinations globally.

On the import side, key buyers of Indian daunorubicin in Uzbekistan include ZANDRA-TASHKENT LLC, LLC <> , GREAT LUX PHARM LLC and 4 others. ZANDRA-TASHKENT LLC is the single largest importer with 3 shipments valued at $52.5K USD.

India's daunorubicin exports to Uzbekistan are driven primarily by a handful of large-scale manufacturers. ZANDRA LIFE SCIENCES PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Uzbekistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZANDRA LIFE SCIENCES PRIVATE LIMITED, ZANDRA LIFE SCIENCES PRIVATE LIMITED , HEET HEALTHCARE PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $8.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as daunorubicin hcl for injection usp 20 mg/vial batch no ol23137 mfh dt 09/2023 exp dt 08/2025 and daunorubicin hcl for injection usp 20 mg/vial batch no ol23135 mfh dt 09/2023 exp dt 08/2025, suggesting that buyers in Uzbekistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ZANDRA-TASHKENT LLC is the largest importer with 3 shipments worth $52.5K USD — representing 63% of all daunorubicin imports from India on this route. A total of 7 buyers are active on this corridor.